ATLATL, one of China’s leading biotech incubators, is seeking to bridge East-West innovation and tap into China's rapidly ...

Breeders did not increase their populations during an investment downturn in 2023, contributing to a supply squeeze.

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

The cost of the monkeys — a proxy for the volume of clinical trials — is projected to reach Rmb150,000 ($21,000) at the start ...

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to ...

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...

China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...

When you or your child next take a dose of antibiotics, consider that 90 percent of its raw ingredients were likely manufactured in China using biotechnologies. China has captured production of ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

EcoCeres has announced that its wholly-owned subsidiary, ECO Biochemical Technology (Zhangjiagang) Company Limited (ECO ...

When you or your child next take a dose of antibiotics, consider that 90 percent of its raw ingredients were likely manufactured in China using biotechnologies. China has captured production of ...